Quayle Frank J, Lowney Jennifer K
Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Clin Colon Rectal Surg. 2006 May;19(2):49-53. doi: 10.1055/s-2006-942344.
Lymphoma involving the colon and rectum is rare and can occur either as primary colorectal lymphoma or as a manifestation of systemic disease. Most patients with primary colorectal lymphoma present with abdominal pain, and obstruction is unusual. Although lesions may be evident on radiographic studies, the findings are generally nonspecific. Historically, aggressive B-cell lymphomas have been the most common gastrointestinal lymphomas reported in the literature. However, recent reports suggest increased rates of mucosa-associated lymphoid tissue (MALT) lymphoma and mantle cell lymphoma (MCL) with increased surveillance.1 Most patients with colorectal lymphoma undergo surgery, but multiagent chemotherapy remains the mainstay of treatment. B-cell lymphomas tend to be most aggressive, with a median survival of about 2 years.
累及结肠和直肠的淋巴瘤较为罕见,可表现为原发性结直肠淋巴瘤或作为全身性疾病的一种表现。大多数原发性结直肠淋巴瘤患者表现为腹痛,肠梗阻并不常见。尽管影像学检查可能显示病变,但结果通常不具有特异性。从历史上看,侵袭性B细胞淋巴瘤一直是文献中报道的最常见的胃肠道淋巴瘤。然而,最近的报告表明,随着监测的增加,黏膜相关淋巴组织(MALT)淋巴瘤和套细胞淋巴瘤(MCL)的发病率有所上升。大多数结直肠淋巴瘤患者接受手术治疗,但多药化疗仍然是主要的治疗方法。B细胞淋巴瘤往往最具侵袭性,中位生存期约为2年。